Latest Breaking News On - Avidity biosciences daily - Page 8 : comparemela.com

Avidity Biosciences, Inc (NASDAQ:RNA) Receives $31 60 Consensus PT from Analysts

Avidity Biosciences, Inc (NASDAQ:RNA) Receives $31 60 Consensus PT from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Pricet rowe associates incNeedham companyAvidity biosciences incAvidity biosciences company profileMorgan stanleyAvidity biosciencesGet free reportStreet corpBiosciences stock downGet freeAvidity biosciences daily

Avidity Biosciences, Inc (NASDAQ:RNA) Shares Sold by Mirador Capital Partners LP

Mirador Capital Partners LP decreased its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 76.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,366 shares of the biotechnology company’s stock after selling 53,395 shares during the period. Mirador Capital […]

Exchange commissionMorgan stanleyAvidity biosciences incNeedham companyPricet rowe associates incMirador capital partnersAvidity biosciencesFree reportCapital partnersStreet corpGet free reportAvidity biosciences dailyNasdaq rnaSec filingsHedge fund holdingsInstitutional investor holdings

Avidity Biosciences (NASDAQ:RNA) Trading 5% Higher

Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) traded up 5% during mid-day trading on Thursday . The stock traded as high as $8.41 and last traded at $8.20. 622,116 shares were traded during mid-day trading, a decline of 42% from the average session volume of 1,076,829 shares. The stock had previously closed […]

Avidity biosciences incJanney montgomery scottCredit suisse groupArtisan partners limited partnershipPrincipal financial group incNeedham companyAvidity biosciencesGet free reportSuisse groupPartners limited partnershipMontgomery scottFinancial groupAvidity biosciences dailyNasdaq rna

Avidity Biosciences (RNA) Scheduled to Post Earnings on Monday

Avidity Biosciences (NASDAQ:RNA – Get Free Report) will be posting its quarterly earnings results on Monday, November 6th. Avidity Biosciences (NASDAQ:RNA – Get Free Report) last released its quarterly earnings data on Tuesday, August 8th. The biotechnology company reported ($0.66) earnings per share for the quarter, beating the consensus estimate of ($0.84) by $0.18. The […]

Ancora advisorsAvidity biosciences incNeedham companyCredit suisse groupAvidity biosciences company profileRoyal bankSchonfeld strategic advisorsAvidity biosciencesGet free reportSuisse groupChardan capitalAvidity biosciences dailyNasdaq rna

Avidity Biosciences (NASDAQ:RNA) vs Generation Bio (NASDAQ:GBIO) Financial Analysis

Avidity Biosciences (NASDAQ:RNA) vs Generation Bio (NASDAQ:GBIO) Financial Analysis
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan diegoTorus therapeutics incGeneration bio coAvidity biosciences incAvidity biosciencesGet free reportGeneration bioGiven avidity bioscienceDuchenne muscular dystrophyTorus therapeuticsAvidity biosciences daily